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Background & aims: Probiotic bacteria are used as food supplement in many different disease settings.
The immune modulating capacity of different strains is not always properly tested which might result in
a suboptimal choice of strains for clinical use.
Methods: The CD4 T cell responses to 19 different gut derived lactic acid bacteria were tested with
different methods to show their diversity in immune modulation and to make a well-founded choice on
which strains to use in future clinical trials.
After co-culture of PBMC with bacteria, the induction of CD4þ T cell subsets (regulatory T cells, T helper
type (TH)1, TH2 and TH17) was analysed by rtPCR of transcription factor mRNA, intracellular FACS
staining of transcription factors and cytokine production.
Results: Bacterial strains all have diverse, unique immune modulatory properties. Strains can induce Treg,
TH1, TH2 and TH17 cells which can be shown at different levels of T cell activation, and is consistent for
most strains tested. For TH1, TH17 and Treg, a positive correlation between the different methods was
found. For TH2 cells the correlation was less consistent.
Conclusions: Probiotic bacteria have very different immune modulating capacities. Analysis of tran-
scription factor mRNA is a suitable method for in vitro characterization of strains prior to clinical
application.
 2011 Elsev ier Ltd and European Soci ety for Clinica l Nutri tion and M etaboli sm. 
Open access under the Elsevier OA license.1. Introduction
Human gut derived bacterial strains are frequently used as
probiotic supplements for a variety of medical affections, including
diarrhoea, constipation, and infections.1 One of the most chal-
lenging objectives of probiotic supplementation however, is to
inﬂuence the immune system.2 Dendritic cells residing in theﬂuorescence activated cell
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 for Clinical Nutrition and Metabollamina propria of the gut are inﬂuenced by food antigens and the
gut microbiota by direct contact of dendrites sampling the gut
lumen and by cytokine production of the epithelial cell layer. These
dendritic cells will subsequently move to draining lymph nodes
and activate T cells there.3 The ﬁrst experiments with supplemen-
tation of lactic acid bacteria were based on the hygiene hypothesis
and had the objective to prevent or cure atopic diseases. In the
original dogma of the TH1-TH2 balance, it was thought that pro-
biotic bacteriawill mainly induce T helper (TH) type 1 cells, thereby
skewing the balance away from the TH2 cells which have an
important role in allergic inﬂammation.4,5
However, in recent years, it became evident that T helper cell
functions are considerably more complex and heterogeneous than
originally thought. The original characterization of the TH1 and TH2
pathways has now been expanded to include additional TH cell
subsets each with their own cytokine repertoire and transcription
factors. These include TH9,6 TH177 and FOXP3þ regulatory T (Treg)
cells.8e11 These subsets also have a role in the initiation andism. Open access under the Elsevier OA license.
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layers of complexity to the pathogenesis of such diseases. This
enforces revisiting and reinterpreting existing ideas on the concept of
probiotic supplementation as a therapeutic option for auto-immune
and allergic diseases. Combating a TH2/TH17 mediated disease such
as allergic asthma through immune regulatory actions of gut derived
bacteria should not only involve the induction of TH1 cells but also
the induction of FOXP3þ Treg. In contrast, probiotics targeting
rheumatoid arthritis or multiple sclerosis should inhibit TH1 and
TH17 responses and promote the induction of TH2 and Treg cells.
Recent papers suggest that gut derived bacterial strains all have
a different inﬂuence on the immune system.12,13 To be able to select
strains suitable for clinical supplementation, the immune inﬂu-
encing and other characteristics of each strain should be docu-
mented accurately.14 The choice of strains should subsequently ﬁt
the experimental setup. We recently showed that the capacity to
induce FOXP3þ regulatory T cells is highly variable between strains.
Some strains were able to induce signiﬁcant numbers of FOXP3þ T
cells with clear regulatory function whereas other strains were
not.15 It is likely that the capacity of gut derived bacterial strains to
either down regulate or induce the differentiation of other TH
subtypes is just as variable.
To select potential strains for future clinical trials we investi-
gated the immune inﬂuencing capacity of 19 bacterial strains of
commonly used species using a high throughput method. The
strains were co-cultured with peripheral blood mononuclear cells
(PBMC) of healthy adult donors and the induction of the different
CD4þ T cell subtypes was evaluated on mRNA and protein level of
signature transcription factors and cytokines. We show that the
capacity of each strain to inﬂuence the immune system is highly
different and that some strains have immune modulatory capac-
ities that are favourable or not.
2. Materials and methods
2.1. Cells and bacteria
PBMC were isolated from healthy adult volunteers using Ficoll-
Isopaque density gradient centrifugation (Ficoll-Paque, Pharmacia,
Upsalla, Sweden). For some experiments, PBMC were depleted of
CD25þ cells using anti-CD25 magnetic beads (BD Biosciences, San
José, CA, USA). PBMC or CD25 PBMC were subsequently co-
cultured with bacteria in a 1:10 ratio (PBMC:CFU) in RPMI 1640
(Gibco, Breda, The Netherlands) supplemented with 1% L-glutamine
(Gibco), 0.5% Penicillin-Streptomycin (Gibco) to prevent bacterial
overgrowth and 10% human AB serum. The 1:10 ratio (based on
viable bacteria) was shown before to induce T cell responses
without apoptosis.15 Bacterial viability was tested by FACS analysis
using the BacLight-kit (Invitrogen, Breda, The Netherlands) Since
the presence of CD4þCD25þ Treg within the total PBMC population
inhibits proliferation of the T cells and protein synthesis, we
increased the sensitivity of some tests by using CD25þ cells
depleted PBMC.
Bacteria (Streptococcus thermophilus W67, Bacillus coagulans
W64, Biﬁdobacterium biﬁdum W28, Biﬁdobacterium breve W25, B.
breve W29, B. breve W6, Biﬁdobacterium lactis W51, B. lactis W52,
Biﬁdobacterium longum W108, Lactobacillus acidophilus W22, L.
acidophilusW55, L. acidophilusW74C, Lactobacillus caseiW20, L. casei
W79, Lactobacillus plantarum W21, L. plantarum W62, Lactobacillus
rhamnosusW71, Lactobacillus salivariusW57, Lactococcus lactisW19)
were obtained from Winclove BioIndustries BV, Amsterdam, The
Netherlands. Bacteria were frozen at 80 C in RPMI 1640 (Gibco)
supplemented with 1% glutamine (Gibco). For each experiment,
a vial was thawed, diluted to the correct concentration and co-
cultured with PBMC. Viability and bacterial cell number of thestrains used was assessed by FACS using the BacLight-kit from
Molecular Probes (Eugene, OR, USA).
For rtPCR, CD4þ T cells were isolated from PBMC after 6 days of
culture using a CD4 T cell enrichment kit (BD Bioscience). CD4 T cell
purity was >95%. Cells were subsequently lysed in Tripure (Roche
Diagnostics, Basel, Switzerland) and frozen at 80 C.
2.2. rtPCR
mRNA was isolated from lysed CD4þ T cells and cDNA prepared
using the iScript cDNA synthese kit from BioRad (Hercules, CA,
USA). cDNAwas frozen at 20 C till use for rtPCR. Primers for b2M
(Fw: CCAGCAGAGAATGGAAAGTC, Rv: GATGCTGCTTACATGTCTCG),
FOXP3 (Fw: TCAAGCACTGCCAGGCG, Rv: CAGGAGCCCTTGTCGGAT),
RORgT (Fw: AAGACTCATCGCCAAAGCAT, Rv: TCCACATGCTGGCTA-
CACA), GATA3 (Fw: CTGCAATGCCTGTGGGCTC, Rv: GACTGCAGG-
GACTCTCGCT) and T-bet(Fw: CCCCAAGGAATTGACAGTTG, Rv:
GGGAAACTAAAGCTCACAAAC) were obtained from TIB Molbiol
(Berlin, Germany). PCR reactionwas performedwith the LightCycler
system from Roche, using SYBR Green I kit or SYBR Green FastStart
kit from Roche. Ct values were compared to values obtained from
mRNA samples isolated from tetanus toxoid stimulated PBMC.
2.3. Flow cytometry
After 6 days of culture, CD25 depleted PBMC were FACS stained
with CD3-PE Cy7 (Biolegend, San Diego, CA, USA), CD4-APC (eBio-
science, San Diego, CA, USA), FOXP3-PerCP Cy 5.5 (clone PCH101,
eBioscience), RORgT-PE (eBioscience), T-bet-FITC (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), and GATA3-PE (BD Biosci-
ence). In other experiments, after 6 days of culture, cells were
stimulated with phorbol 12-myristate 13-acetate (PMA, 5 ng/ml)
and Ionomycin (1 mg/ml) in the presence of monensin (Golgistop,
BD Biosciences) for 4 h. Subsequently cells were intracellular FACS
stained for IL-10-APC (Biolegend), IL-17a-Alexa Fluor 488 (eBio-
science), IFNg-PE (BD Bioscience) or IL-4-PE (BD Bioscience).
Cells were analysed using a FACS Canto with FACS Diva software
(BD Biosciences).
2.4. Statistics
Statistical signiﬁcance was tested using Prism 4.0 for Macintosh
with a KruskaleWallis test. p  0.05 was considered signiﬁcant.
Dunn’s multiple comparisons test was used to identify signiﬁcant
differences between strains. Correlations between experiments
were tested with Spearman’s rank correlation.
3. Results
In order to investigate the immune modulatory properties of
strains with a high throughput method, PBMC from healthy
volunteers were co-cultured with the strains in a 1:10 ratio. After 6
days of culture, CD4þ T cells were isolated and lysed. Subsequently,
the expression of transcription factors speciﬁc for CD4þ T cell
subsets was investigated by real time PCR. FOXP3, T-bet, GATA3,
and RORgT are thought to be speciﬁc for Treg, TH1, TH2 and TH17
cells respectively.16 The expression of the transcription factor
mRNA of co-cultured PBMC was subsequently compared to the
expression in the absence of bacteria in the culture medium. As
shown in Fig. 1aed, many differences between strains were
observed. Some strains seem to activate different subtypes of T
helper cells (e.g. L. salivarius, FOXP3 and RORgT, Fig. 1a, c), while
others speciﬁcally induce one subtype (e.g. L. lactis W19, T-bet,
Fig. 1b). Although the differences between the strains were signif-
icant for all individual transcription factors (KruskaleWallis,
Fig. 1. Transcription factor mRNA in CD4þ T cells after culture. Fold induction of the transcription of mRNA of FOXP3 for Treg (A), T-bet for TH1 (B), GATA3 for TH2 (C), and RORgT for
TH17 (D) of CD4 T cells in PBMC co-cultured with probiotic strains compared to cells cultured in medium alone. CD4 cells were isolated from PBMC after 6 days of culture, lysed, and
the transcription of speciﬁc mRNA compared to b2M mRNA transcription by rtPCR. Differences between strains in transcription of mRNA were signiﬁcant for all genes tested
(P  0.01, KruskaleWallis), n ¼ 5.
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in GATA3 expression were less pronounced than the differences in
for example T-bet and RORgT mRNA expression. No post-hoc tests
were performed as the Bonferroni correction with these many
strains and comparisons would reduce the probability of ﬁnding
signiﬁcant differences.
mRNA expression of the transcription factors deﬁning the CD4 T
cells subsets is a good indication for the fate of the T cells. However,
mRNA does not necessarily lead to stable protein expression. In
order to show that different T cell subsets are actually induced in
the co-cultures, we subsequently measured transcription factor
protein expression by intracellular FACS staining with a smaller
number of strains. For these experiments we selected strains that
showed an interesting proﬁle in the expression of mRNA:
L. plantarum W21 and B. lactis W52 for FOXP3 mRNA induction,
S. thermophilusW67 for GATA3, L. lactisW19 T-bet, L. salivariusW57
both FOXP3 and RORgT. CD25 depleted PBMC were co-cultured
with these strains for 6 days. At day 6 FACS staining was performed.
Figure 2aed shows the percentages of CD3þCD4þ Tcells positive
for the protein of the speciﬁc transcription factor after culture with
the strains mentioned. Most of the strains that induced mRNA ofa speciﬁc transcription factor also induced expression of the
protein. The strains L. plantarumW21 and L. salivarius that induced
FOXP3 mRNA also induced high percentages of FOXP3þ CD4 cells.
L. lactis W19 and L. salivarius W57 also showed a similar pattern in
mRNA and protein expression for T-bet and RORgT expression
respectively. On top of that, signiﬁcant differences between strains
were observed in the induction of speciﬁc Tcell subsets. L. salivarius
W57 was shown to be the most potent inducer of FOXP3þ cells,
whereas L. lactis W19 induced the most T-betþ cells. These two
strains induced the most RORgTþ cells as well.
Most CD4þ T cells produce cytokines in order to perform their
biological function. For each T helper cell subset, the proﬁle of
cytokines produced is different (IL-10 for cells with a regulatory
phenotype, IFNg, IL-4 and IL-17 for TH1, TH2, TH17 cells respec-
tively). To show that the T cells induced in our previous experi-
ments really produce their speciﬁc effector molecules, we again
co-cultured CD25 depleted PBMC with the selected strains and
performed FACS staining after 4 h incubation with PMA/Ionomycin
and monensin. Figure 4aed shows that most cytokine proﬁles are
comparable with the proﬁles of transcription factor mRNA and
protein. Speciﬁcally, the strains that induced protein expression of
Fig. 2. Transcription factor protein in CD4þ T cells after culture. Percentage of FOXP3þ (A), T-betþ (B), GATA3þ (C), and RORgTþ (D) CD3þCD4þ T cells. After 6 days of culture of CD25
depleted PBMC, cells were FACS stained for transcription factors. *, signiﬁcant difference according to Dunn’s multiple comparisons test. Gating strategy is shown in E. n ¼ 6.
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This is nicely shown for T-bet expression and IFNg production, and
for RORgT and IL-17 production. The strains that signiﬁcantly
induced the highest percentage of T-betþ and RORgTþ cells, also did
so for the corresponding cytokines. GATA3 expression is less in
accordance with IL-4 production. Finally, L. plantarum W21 and
L. salivariusW57 induce both FOXP3þ cells and IL-10 producing CD4
T cells although there was no signiﬁcant difference found for the IL-
10 producing cells.
In order to show that our methods are consistent with each
other, we performed a Spearman’s rank correlation test with the
strains that were tested with all methods. We analysed the corre-
lation between the percentage of cytokine producing cells and the
upregulation of mRNA for the speciﬁc transcription factor or the
percentage of transcription factor positive cells measured by FACS
(Fig. 4). Although for most correlations signiﬁcance was not
reached, the methods used to test the induction of Treg, TH1 and
TH17 cells all have a positive relation (Spearman r > 0). The
measurements on the induction of TH2 cells however also showed
a negative correlation (Spearman r< 0) between GATA3mRNA and
IL-4 producing cell percentage, indicating that our methods were
not consistent for this cell type.
As shown in Fig. 4a, we observed a considerable inter-donor
variation with most techniques used. Therefore, we constructed
a heat map to ﬁnd out whether most donors had a comparable
pattern of reaction towards the different strains (Fig. 4b). Indeed,
some donors react more or different than others. However, most
donors show consistent reaction towards the strains, formingclusters of differentiation towards a certain T helper subtype. This
was observed for all strains and techniques used.
4. Discussion
Strains of human gut derived lactic acid bacteria have potent
capacities to inﬂuence the immune system when used as
a supplement. Each strain seems to be unique in the subtypes of
CD4 T cells that it promotes. We and others already showed this for
Treg induction15 and for the production of cytokines.17 We now
extend these observations by showing that lactic acid bacteria
signiﬁcantly differ in their capacity to promote TH1 cells, but also
TH2, Treg and TH17 cells. This ﬁnding adds important information
to the concept of probiotic use as a food supplement for the
prevention or treatment of immune mediated diseases such as
allergies and auto-immune diseases. Our data suggest that not any
strain of probiotic bacteria is able to mount a favourable immune
response for any disease and that the strain used can make an
important difference for the outcome of clinical experiments. For
example, it is likely that the inconsistencies in the outcome of
studies such as on the prevention of atopic disorders is due to
subtle differences in the strains used.18e21 Studies conducted with
the same strain have more consistent outcome.22
As it is important to monitor the immune inﬂuencing capacities
of strains, a reliable high throughput method is a helpful tool to
screen for wanted and unwanted effects of probiotics. Co-culture of
strains with PBMC and subsequent transcription factor mRNA
analyses seems suitable for this purpose. The activation or
Fig. 3. Cytokine production by CD4þ T cells after culture. Percentage of IL-10þ (A), IFNgþ (B), IL-4þ (C) and IL-17þ (D) CD3þCD4þ T cells. After 6 days of culture of CD25 depleted
PBMC, cells were restimulated with PMA/Ionomycin for 4 h in the presence of monensin. Cells were subsequently FACS stained for intracellular cytokines. *, signiﬁcant difference
according to Dunn’s multiple comparisons test. Gating strategy is shown in E. n ¼ 6.
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levels; the transcription factor mRNA content, transcription factor
protein as well as cytokine production. These methods correlated
well for most T cell subsets, making all methods used in this
research possible candidates for high throughput measurements of
large numbers of strains, depending on a laboratory’s possibilities.
Most in vitro analysis of immune modulating properties of
bacterial strainsareperformedbymeasurements oncytokines in the
supernatants of PBMC or other cell cultures in the presence of
bacteria.17,23 Up- or downregulation of surfacemarkers on dendritic
cells is also a common approach.13 Although these methods deﬁ-
nitely havebeneﬁts (broad scan of immune responses), the response
of the adaptive immune systemneeds to be addressed aswell. Tcells
are likely candidates for local immune activity outside the gut
making these cells the targets in settings as for example eczema and
asthma. Analysis of T cell responses as described here can perfectly
be combined with analysis of cytokines in the supernatant of the
same culture, increasing the value and reliability of the screening.
Because of high variability between donors, and the use of
different donors for each experiment, the correlations were not
signiﬁcant for all tests. Nevertheless, the correlation was shown to
be positive for Treg, TH1 and TH17 cell induction, indicating that
the strains that induce mRNA of a speciﬁc T cell type will also
induce a high percentage of speciﬁc cytokine producing cells. Our
methods showed not to be suitable for themeasurement of TH2 cell
induction by probiotics. This can be due to the fact that GATA3 is
known to be necessary for more cellular processes than TH2
differentiation,24 or timing of the measurements. Of course, eachmRNA, and protein has its own kinetics, making it hard to measure
all processes with a few tests on a few time points. Possibly the
timing for TH2 mRNA and proteins was suboptimal.
Although strains have a clear tendency to induce either subtype
of T helper cell, this effect is not shown with identical strength for
all donors tested, resulting in considerable variation in our results.
This ﬁnding, as depicted in Fig. 4b, adds another layer to the
complex ﬁeld of immune modulation by probiotics. Possibly the
variation in the human population in reactivity towards a certain
bacterial strain warrants a personalized approach. Before supple-
menting a patient with a certain strain, the quality and quantity of
the patients T cell response towards this strain can be determined
with either of the described methods. On the other hand, supple-
mentationwith a probiotic mixture (e.g. a multi-species probiotics)
of strains with a certain immune modulating capacity might be
beneﬁcial for a broader group of individuals.25 In vitro analysis of T
cell responses towards such a mixture would be of great interest.
Whether the induction of different T cell subsets is also
consistent in vivo and whether these cells are able to inﬂuence
immune mediated diseases still remains to be tested. It has been
shown by several authors that in vitro experiments do not neces-
sarily correlate with clinical outcome.26,27 Nevertheless, application
of probiotic strains without proper knowledge on their immuno-
logical capacities can also have unwanted effects.28 In vitro research
using human PBMC cultures can give a good indication, although
this does not perfectly mimic the in vivo situation. Both in vitro and
in vivo parameters should be selected carefully in order to ﬁnd and
correlate effects of probiotics. Testing the strains used here in
AB
Fig. 4. Analysis of correlations and donor variability. Correlation between expression of transcription factor mRNA and percentage cytokine producing cells (A, left part) and
percentage of transcription factor positive cells and percentage cytokine producing cells (A, right part). Spearman r is given as a measure of correlation. *, signiﬁcant correlation
according to Spearman’s signed rank test. n ¼ 5 for mRNA data and n ¼ 6 for FACS data of transcription factor expression and cytokine production. Heat map (B) indicating the
responses of all donors towards the strains used measured by transcription factor mRNA PCR (FOXP3, T-bet, GATA3, RORgT respectively), transcription factor protein FACS (FOXP3,
T-bet, GATA3, RORgT respectively) or cytokine FACS (IL-10, IFNg, IL-4, IL-17 respectively) as depicted in the Figs. 1e3. The legend indicates the values corresponding to the colours for
each technique. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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models, and comparing the results to our in vitro data would be of
great interest. Treg inducing strains will likely have a beneﬁcial
effect on these diseases, whereas TH1, TH17 or TH2 inducing strains
might aggravate disease.
There is still much to learn regarding the determinants of the
diverse immune responses elicited bydifferent bacterial strains. The
identiﬁcation of closely related strains that differ in the type of
immune response they elicit is of special interest. In our study
L. acidophilus W74c and L. acidophilus W22 showed remarkable
differences in their capacity to induce RORgT. Further screening of
the genomes of these strains using micro-array might give more
insight in the speciﬁc gene(s) responsible for the immune modu-
lation. That the type of immune response induced by gut derived
bacteria can depend on one single molecule has elegantly been
shown by a study of Mazmanian et al.29 In this study it was
demonstrated that Bacteroides fragilis depends on polysaccharide A
(PSA) to protect against inﬂammation in an experimental colitis
model and that PSA is sufﬁcient for the protective effect. Also, the
capacity of strains to ligate certain receptors expressed by the innate
immune system can differentiate between activation of the immunesystem. Attachment to DC-SIGN expressed byDC has been shown to
prime DC to induce FOXP3þ regulatory T cells.30 The differences we
observe in in vitro immune modulation between strains might also
be partially explained by ligation of DC-SIGN or other receptors.
We conclude that to make well-founded choices on the type of
probiotic strains to be used for clinical application, in vitro moni-
toring of the immunological effects of the strains using a high
throughput method is highly recommendable.15 By building on our
current knowledge of strain speciﬁc immune modulatory effects it
may become possible to design clinically effective, bacteria based
strategies to maintain and promote health.
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